News ArchivesRead News
Parkinson’s Pump Undergoes Experimental Study
Friday December 26, 2003
GDNF Drug May Help Reverse Symptoms
Portland, OR, December 23, 2003(Ivanhoe Broadcast News ) - As many as 1 million Americans have Parkinsons disease. There are several treatment options for the symptoms of Parkinsons, but they also come with side effects. Now doctors may have found a way to not only treat the symptoms, but also reverse the disease.
Fourteen years ago, Greg Moore was diagnosed with Parkinsons disease. The medication he takes for the disease can only do so much.
"Turning over in bed is very difficult for me to do," he said. "Going through a stack of papers is a very difficult thing to do."
Two months ago, he became the first person in the United States to join an experimental study on Parkinsons disease.
Dr. Kim J. Burchiel placed two catheters under Moores skin that run down his chest and attach to pumps implanted in his abdomen. For some patients in the study, the pumps deliver a placebo. For others, its a substance called glial- derived neurotrophic factor -- or GDNF.
"In animal models, GDNF seems to be very good at reversing or, I dont want to use the word cure, but correcting Parkinsonism," said Dr. John G. Nutt, a neurologist at Oregon Health & Science University in Portland.
The drug seems to coax dying dopamine nerve cells back into production. In a small trial in England, patients reported dramatic improvement in movement and coordination.
"They got to the point where they were having much less problems with their Parkinsonism. Some have reduced their drugs markedly as well," Nutt said.
Moore doesnt know yet if he received the real drug, but hes hopeful.
"Its nothing more than a possibility right now, but its very exciting to me," he said.
The trial will last six months and involves only 35 patients worldwide. Risks of the surgery include infection and bleeding. The risks of GDNF are not known, but it is a substance produced naturally by the brain.
If you would like more information, please contact: The Parkinson Center of Oregon (503) 494-5285
Recent NewsMay 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright
Mar 30 - Hepatitis Tied to Parkinson's Risk
Mar 28 - Elon Musk's new company said to see brain-computer link